PAVmed to Hold Business Update Conference Call and Webcast on December 7th
Friday, December 2nd 2016 at 12:00pm UTC – Third Quarter 2016 Financial Results Announced – NEW YORK–(BUSINESS WIRE)– PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical...
View ArticleNew Phase 2 Results Show Investigational Compound Glasdegib Improved Overall...
Saturday, December 3rd 2016 at 6:00pm UTC Data on First Smoothened Inhibitor to Show Clinical Benefit in This Patient Population to be Presented During Oral Session at 2016 ASH Annual Meeting NEW...
View Article22nd Century to Present Overview of Company’s Medical Marijuana and...
Monday, December 5th 2016 at 3:00pm UTC “Research is opening exciting new paths to medically-important and industrially-important products.” CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc....
View ArticleKYOCERA Medical Corporation Receives FDA 510(k) Clearance for Initia® Total...
Monday, December 5th 2016 at 1:05pm UTC SAN DIEGO–(BUSINESS WIRE)– Kyocera Medical Corporation, a leading manufacturer of implantable systems and advanced ceramic components, today announced it has...
View ArticleKadmon Presents Encouraging Data on Tesevatinib in EGFR-Mutated Non-Small...
Tuesday, December 6th 2016 at 1:30pm UTC — Eleven of 13 Enrolled Patients Showed No CNS Disease Progression on Tesevatinib — — Additional Studies Planned, Including First-Line Study in Patients with...
View ArticlePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare...
Tuesday, December 6th 2016 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and CEO, at the...
View ArticleRenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To...
Tuesday, December 6th 2016 at 2:15pm UTC NEW YORK & PITTSBURGH–(BUSINESS WIRE)– RenovaCare, Inc., (RCAR), developer of the patented CellMist™ and SkinGun™ technologies* for isolating and spraying...
View ArticlePIN Pharma to Present at 2016 New England Venture Summit
Monday, December 5th 2016 at 5:17pm UTC NEW YORK–(BUSINESS WIRE)– PIN Pharma, a pre-IND immunotherapy company focused on modulating the immune system in oncology, today announced it will be presenting...
View ArticleKadmon Submits Abbreviated New Drug Application Filing for Trientine...
Monday, December 5th 2016 at 9:01pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) (“Kadmon” or the “Company”) today announced that it has submitted an Abbreviated New Drug...
View ArticleImmuno-Oncology Market Could Generate Peak Sales over $35 Billion by 2022
Wednesday, December 7th 2016 at 1:00pm UTC Major Recent Developments and Upcoming Catalysts in the Immuno-Oncology Field NEW YORK–(BUSINESS WIRE)– BioPharm Insight (BPI), the most comprehensive life...
View ArticleAxcella to Present at the BMO Capital Markets 2016 Prescriptions for Success...
Wednesday, December 7th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Axcella, a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino...
View ArticleRa Pharmaceuticals to Present at the BMO Capital Markets Prescriptions for...
Wednesday, December 7th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ra Pharmaceuticals (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of...
View ArticleTeva to Present at the Citi 2016 Global Healthcare Conference
Wednesday, December 7th 2016 at 2:05pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Citi 2016 Global Healthcare Conference....
View ArticleMedicrea to Host Key Opinion Leader Breakfast in New York City for Investors...
Thursday, December 8th 2016 at 6:30am UTC LYON, France & NEW YORK–(BUSINESS WIRE)– The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the development and...
View ArticleNovocure Announces Agenda for Research and Development Day on Dec. 12, 2016
Thursday, December 8th 2016 at 12:42pm UTC Speakers will share new data from Novocure’s phase 2 pilot trials in pancreatic and ovarian cancers ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:...
View ArticleBristol-Myers Squibb Announces Dividend Increase
Thursday, December 8th 2016 at 9:15pm UTC NEW YORK–(BUSINESS WIRE)– The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared an increase of 2.6% percent in the company’s...
View ArticleAnesthesia Business Consultants Attends the 70th Annual PostGraduate Assembly...
Thursday, December 8th 2016 at 5:20pm UTC JACKSON, Mich.–(BUSINESS WIRE)– Anesthesia Business Consultants (ABC), a leading provider in billing and practice management for the anesthesia and pain...
View ArticleAlnylam to Webcast R&D Day
Thursday, December 8th 2016 at 9:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast...
View ArticleSynergy Pharmaceuticals Announces Positive Results in First Phase 3 Trial of...
Friday, December 9th 2016 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical...
View ArticleBristol-Myers Squibb to Announce Results for Fourth Quarter 2016 on January...
Friday, December 9th 2016 at 9:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2016 on Thursday, January 26, 2017. During a...
View Article